Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.
Month: November 2021
GCV Symposium 2021: Impact keynote – A climate change innovator
Hitachi’s chief environmental officer Alistair Dormer gave a keynote on the firm’s commitment to sustainability through innovation.
GCV Symposium 2021: Day 2 welcoming remarks
Introductions of the second day of the 10th GCV Symposium featured GCV’s James Mawson and chair Eileen Tanghal from In-Q-Tel.
GCV Symposium 2021: Panel – Sustainability investments
Jeremy Nicholls from UN’s Development Programme and Natural Capital Research’s Beccy Wilebore spoke about avoiding the greenwash to locate the best source of capital.
Daily Deal Round Up: November 3, 2021
Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.
GCV Symposium 2021: Neom’s energy vision
Jens Madrian introduces Neom Energy, which is set to start investing in technology companies from 2023.
GCV Symposium 2021: Panel – Deep diving into deep tech
Salience Labs’ founder and CEO Vaysh Kewada, Israel Venture Partner’s founder Jacob Bryce and Business Innovation Consulting’s principal director Ezra Carlson spoke about challenges and potential of investing in deep tech.
Giri goes to Splunk
Rohit Giri left a director of corporate development role at BigCommerce to take up a similar position at Splunk, where he will help run its Splunk Ventures unit.
GCV Symposium 2021: Case study – Swisscom Ventures & Rready
Stefan Kuentz introduced Rready and explained how a Silicon Valley-developed innovation method is scaling globally as a Swisscom Ventures spinout.
GCV Symposium 2021: Panel – A second run for cleantech
Odqa CEO Gediz Karaca and Mixergy executive chair David Pinder talked about the new cleantech wave in a panel moderated by Rolls-Royce’s R2 Data Labs group director Caroline Gorski.
GCV Symposium 2021: TDK Ventures two years on
GCV’s James Mawson interviewed TDK Ventures‘ Nicolas Sauvage about his unit’s track record since it was founded in 2019.
GCV Symposium 2021: Panel – It is all relative
Aviva Ventures’ Ben Luckett and Fidelity International Strategic Ventures’ Alokik Advani discussed how to make the world a better place through ESG investing.
Coca-Cola fortifies itself with Bodyarmor
Coca-Cola paid $5.6bn for the 85% of the sports drink brand it did not already own, having invested an undisclosed amount three years ago.
Nubank files for dual listing
The Tencent and Berkshire Hathaway-backed digital bank is seeking to grow its valuation from $30bn in June to over $50m in flotations in the US and Brazil.